Harbo H F, Celius E G, Vartdal F, Spurkland A
Institute of Transplantation Immunology, The National Hospital, Oslo, Norway.
Tissue Antigens. 1999 Jan;53(1):106-10. doi: 10.1034/j.1399-0039.1999.530112.x.
The human cytotoxic T-lymphocyte-associated protein 4 (CTLA4) gene may be a candidate susceptibility gene in multiple sclerosis (MS). In this study the distribution of the dimorphisms of exon 1 (+49 A/G) and promoter (-318 C/T) regions of the CTLA4 gene was analysed in 296 unrelated Norwegian MS patients and 271 matched controls by polymerase chain reaction and restriction fragment length polymorphism. The frequency of the exon 1 (+49) A-G genotype was increased in patients (57%) compared with controls (44%) (Pcorrected=0.01), and even more increased in patients with relapsing remitting MS (59%) (Pcorrected=0.006). No other significant differences were found between clinical subgroups of patients or between HLA-DRB11501, DQB10602-positive and negative patients and controls.
人类细胞毒性T淋巴细胞相关蛋白4(CTLA4)基因可能是多发性硬化症(MS)的一个候选易感基因。在本研究中,通过聚合酶链反应和限制性片段长度多态性分析了296名无亲缘关系的挪威MS患者和271名匹配对照中CTLA4基因外显子1(+49 A/G)和启动子(-318 C/T)区域二态性的分布。与对照(44%)相比,患者中外显子1(+49)A-G基因型的频率增加(57%)(校正P=0.01),在复发缓解型MS患者中增加得更多(59%)(校正P=0.006)。在患者的临床亚组之间,或HLA-DRB11501、DQB10602阳性和阴性患者与对照之间未发现其他显著差异。